Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$1,065.30
% of Total Estimate Gain
2.63%

Adaptive Hedged High Income Fund's Abbott Laboratories Holding Summary

As of 2021-08-31, Adaptive Hedged High Income Fund held - shares of Abbott Laboratories(ABT), totaling N/A. This investment constitutes 0% of their stock portfolio, and Adaptive Hedged High Income Fund now holds 0% of the outstanding Abbott Laboratories(ABT) stock.

The initial trade took place in 2021Q1. And since then Adaptive Hedged High Income Fund has made 2 purchases of ABT, at an average price of $114.88, for a total of 352.00 shares. In addition, there have been 1 sales at an average price of $117.91 for 352.00 shares. Based on historical transaction data and ABT's current price of $124.39, Adaptive Hedged High Income Fund's estimated gain on his ABT holdings is $1,065.30, reflecting a 2.63% gain to date.

Adaptive Hedged High Income Fund ABT ($124.39) Holding Chart

Adaptive Hedged High Income Fund ABT ($124.39) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1